Anhui Fengyuan Pharmaceutical Co Ltd Net Asset Momentum
Anhui Fengyuan Pharmaceutical Co Ltd net asset momentum. Anhui Fengyuan Pharmaceutical Co Ltd (000153) recorded a net asset momentum of 3.9% as of December 2025, with net assets of CN¥2.13 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 000153 book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Anhui Fengyuan Pharmaceutical Co Ltd (1997–2025)
Net asset momentum of Anhui Fengyuan Pharmaceutical Co Ltd from 1997 to 2025. This chart tracks Anhui Fengyuan Pharmaceutical Co Ltd's year-over-year net asset growth across 29 annual reporting periods from 1997 to 2025. The most recent momentum reading is +3.9%, with net assets of CN¥2.13 Billion CNY as of December 2025. Check Anhui Fengyuan Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Anhui Fengyuan Pharmaceutical Co Ltd Net Asset Momentum by Year (1997–2025)
Anhui Fengyuan Pharmaceutical Co Ltd net asset momentum by year from 1997 to 2025. The table below shows the complete annual net asset history for Anhui Fengyuan Pharmaceutical Co Ltd from 1997 to 2025, covering 29 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 000153 market cap.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥2.13 Billion | CN¥5.06 Billion | CN¥2.93 Billion | ▲ +3.9% |
| 2024 | CN¥2.05 Billion | CN¥4.70 Billion | CN¥2.65 Billion | ▲ +6.6% |
| 2023 | CN¥1.92 Billion | CN¥4.39 Billion | CN¥2.47 Billion | ▲ +9.3% |
| 2022 | CN¥1.75 Billion | CN¥4.47 Billion | CN¥2.71 Billion | ▲ +12.7% |
| 2021 | CN¥1.56 Billion | CN¥3.82 Billion | CN¥2.26 Billion | ▲ +7.6% |
| 2020 | CN¥1.45 Billion | CN¥3.64 Billion | CN¥2.19 Billion | ▲ +9.1% |
| 2019 | CN¥1.33 Billion | CN¥3.56 Billion | CN¥2.23 Billion | ▲ +2.7% |
| 2018 | CN¥1.29 Billion | CN¥3.01 Billion | CN¥1.72 Billion | ▲ +5.8% |
| 2017 | CN¥1.22 Billion | CN¥2.77 Billion | CN¥1.55 Billion | ▲ +5.9% |
| 2016 | CN¥1.15 Billion | CN¥2.49 Billion | CN¥1.34 Billion | ▼ -2.7% |
| 2015 | CN¥1.18 Billion | CN¥2.31 Billion | CN¥1.12 Billion | ▲ +3.3% |
| 2014 | CN¥1.15 Billion | CN¥2.24 Billion | CN¥1.09 Billion | ▲ +8.8% |
| 2013 | CN¥1.05 Billion | CN¥1.98 Billion | CN¥926.72 Million | ▲ +36.0% |
| 2012 | CN¥775.01 Million | CN¥1.45 Billion | CN¥675.47 Million | ▲ +1.3% |
| 2011 | CN¥765.24 Million | CN¥1.32 Billion | CN¥552.99 Million | ▲ +1.5% |
| 2010 | CN¥753.81 Million | CN¥1.28 Billion | CN¥522.02 Million | ▲ +11.1% |
| 2009 | CN¥678.70 Million | CN¥1.21 Billion | CN¥526.78 Million | ▲ +3.8% |
| 2008 | CN¥654.09 Million | CN¥1.17 Billion | CN¥511.47 Million | ▲ +2.4% |
| 2007 | CN¥638.89 Million | CN¥1.09 Billion | CN¥449.73 Million | ▲ +3.0% |
| 2006 | CN¥620.49 Million | CN¥1.07 Billion | CN¥445.10 Million | ▲ +3.5% |
| 2005 | CN¥599.59 Million | CN¥1.09 Billion | CN¥493.08 Million | ▲ +1.4% |
| 2004 | CN¥591.07 Million | CN¥895.92 Million | CN¥304.86 Million | ▲ +2.6% |
| 2003 | CN¥576.00 Million | CN¥736.92 Million | CN¥160.93 Million | ▲ +2.7% |
| 2002 | CN¥560.87 Million | CN¥684.42 Million | CN¥123.55 Million | ▲ +4.6% |
| 2001 | CN¥536.15 Million | CN¥709.48 Million | CN¥173.33 Million | ▲ +0.7% |
| 2000 | CN¥532.50 Million | CN¥634.79 Million | CN¥102.28 Million | ▲ +905.1% |
| 1999 | CN¥52.98 Million | CN¥134.63 Million | CN¥81.65 Million | ▲ +19.5% |
| 1998 | CN¥44.35 Million | CN¥110.33 Million | CN¥65.98 Million | ▲ +84.6% |
| 1997 | CN¥24.03 Million | CN¥58.92 Million | CN¥34.89 Million | — |